Showing results (21-30 of 177) with videos related to

Sort By:
Pageof 18
The Cochrane Database of Systematic Reviews|April 22, 2021
PARP (Poly ADP-Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancerAmelia M Taylor, David Lok Hang Chan, Martin Tio, et al.
Nature Reviews. Clinical Oncology|June 15, 2016
Counselling framework for moderate-penetrance cancer-susceptibility mutationsNadine Tung, Susan M Domchek, Zsofia Stadler, et al.
Breast Cancer Research and Treatment|September 28, 2023
Impact of reactive changes on multigene testing: histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scoresAnne Grabenstetter, Edi Brogi, Donna M Thompson, et al.
Critical Reviews in Oncology/Hematology|July 27, 2024
The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic reviewAreen Abu Remilah, Bilal Krayim, Eitan Amir, et al.
Breast Cancer Research and Treatment|October 13, 2021
Penetrance of male breast cancer susceptibility genes: a systematic reviewReem S Chamseddine, Cathy Wang, Kanhua Yin, et al.
JCO Precision Oncology|January 16, 2020
Decision-Making Preferences About Secondary Germline Findings That Arise From Tumor Genomic Profiling Among Patients With Advanced CancersJada G Hamilton, Elyse Shuk, Margaux Genoff Garzon, et al.
Public Health Genomics|November 12, 2015
Genetic Testing Awareness and Attitudes among Latinos: Exploring Shared Perceptions and Gender-Based DifferencesJada G Hamilton, Elyse Shuk, Guedy Arniella, et al.
NPJ Breast Cancer|July 26, 2024
Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriersSara P Myers, Varadan Sevilimedu, Andrea V Barrio, et al.
Cancer|March 26, 2003
Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutationsNoah D Kauff, Edi Brogi, Lauren Scheuer, et al.
Annals of Surgical Oncology|October 5, 2023
Mutational Status is Associated with a Higher Rate of Pathologic Complete Response After Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast CancerSara P Myers, Varadan Sevilimedu, Andrea V Barrio, et al.
Pageof 18